PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1515483
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1515483
Asia Pacific Personalized Medicine Market, By Product, By Application, By End-User, By Country - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
REPORT HIGHLIGHT
Asia Pacific Personalized Medicine Market was valued at USD 98,879.23 million in 2023, expanding at a CAGR of 11.8% from 2024 to 2032.
Personalized medicine, also referred to as precision medicine, is an innovative strategy for customizing medical treatment according to the individual characteristics of each patient. This approach takes into account the variations in genes, environment, and lifestyle for every individual, enabling more accurate and effective interventions. By utilizing the unique genetic makeup of each patient, personalized medicine is gradually surpassing the limitations of traditional medical practices. It can be seen as an expansion of conventional methods in comprehending and addressing diseases. With the aid of more precise tools, physicians can now choose a therapy or treatment protocol based on a patient's molecular profile. This not only reduces the risk of harmful side effects and ensures a more successful outcome, but also helps in controlling costs when compared to a trial-and-error approach to disease treatment.
Asia Pacific Personalized Medicine Market- Market Dynamics
The increasing need for innovative drug development to address the growing prevalence of cancer and various diseases worldwide is anticipated to propel market expansion
Personalized medicine is centered on the creation of medications that specifically target the molecular pathways involved in the progression of diseases. This approach has the potential to result in more efficient treatments that come with fewer negative effects when compared to traditional therapies. The incidence of cancer is increasing on a global scale, and this trend is also evident in the Asia Pacific region. As a result, there is a demanding need for the development of innovative and targeted therapies that can offer more effective treatment options while minimizing side effects. According to the World Health Organization, cancer is a leading cause of death worldwide, accounting for approximately 10 million deaths in 2020, which is nearly one in six deaths. Additionally, the rapid advancements in genomics, proteomics, and bioinformatics technologies present opportunities for market growth. However, it is important to note that the complex regulatory landscape may pose restrictions on the market.
Asia Pacific Personalized Medicine Market- Key Insights
As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 11.8% over the forecast period (2024-2032)
Based on Product segmentation, Personalized Nutrition, and Wellness was predicted to show maximum market share in the year 2023
Based on Application segmentation, Oncology was the leading type in 2023
Based on End-user segmentation, Hospitals was the leading type in 2023
Based on countries, China was the leading revenue generator in 2023
Asia Pacific Personalized Medicine Market- Segmentation Analysis:
The Asia Pacific Personalized Medicine Market is segmented based on Product, Application, End-User, and Country.
The market is segmented into four groups according to the type of product: Personalized Medicine Diagnostics, Personalized Medicine Therapeutics, Personalized Medical Care, and Personalized Nutrition and Wellness. Among these categories, Personalized Nutrition and Wellness holds the largest market share. Personalized nutrition and wellness focuses on customizing dietary and lifestyle suggestions to meet an individual's specific genetic, biochemical, and lifestyle requirements. This personalized approach has the potential to enhance health outcomes, prevent diseases, and promote overall well-being.
The market is divided into four categories based on Application: Oncology, CNS, Immunology, Respiratory, and Others. Oncology dominates the market. Personalized medicine, particularly in oncology, represents a transformative approach to cancer diagnosis and treatment.
The market is segmented into three groups according to End-User: Hospitals, Diagnostic Centers, Research & Academic Institutes, and Other entities. Hospitals are the dominant force in the market, playing a vital role in advancing and expanding the personalized medicine sector. Serving as primary healthcare facilities, hospitals lead the way in incorporating personalized medicine into medical care, providing customized therapies, and enhancing patient results.
Asia Pacific Personalized Medicine Market- Geographical Insights
The examination of the Asia Pacific Personalized Medicine market covers nations like India, China, South Korea, Japan, Australia, Thailand, Indonesia, and the Philippines, in addition to the rest of the Asia Pacific (APAC) region. China leads the way in the Personalized Medicine market, mainly due to its strong healthcare infrastructure and rising healthcare expenditures. China's leadership in the personalized medicine sector is supported by its solid healthcare infrastructure, growing healthcare expenditures, and dedication to innovation.
Asia Pacific Personalized Medicine Market- Competitive Landscape:
The Asia Pacific personalized medicine market is witnessing intense competition among several prominent players, all striving to establish a strong foothold in this rapidly evolving sector. This competition is driven by the need to develop cutting-edge technologies, groundbreaking treatments, and comprehensive healthcare solutions tailored to the specific needs of individual patients. There is a constant focus on investing in research and development to revolutionize and improve genetic testing, molecular diagnostics, and targeted therapies. Companies are committed to introducing innovative technologies and expanding their product portfolios. Success in this highly competitive market pivots on the ability to navigate the regulatory landscape, ensure data security, and create innovative and cost-effective personalized treatments and diagnostics.
Recent Developments:
On 9 Feb. 2023, Roche nowadays announced that it has expanded its collaboration with Janssen Biotech Inc. to create companion diagnostics for targeted therapies, further strengthening research and innovation activities.
GE HealthCare will be participating in the Society of Nuclear Medicine and Molecular Imaging (SNMMI) annual meeting on June 07, 2024, alongside leading medical and academic institutions. The focus will be on addressing the current healthcare environment and introducing innovative precision care tools to cater to the urgent requirements of healthcare providers, particularly in terms of making technologies and solutions more accessible for the worldwide implementation of personalized medicine.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
ASIA PACIFIC PERSONALIZED MEDICINE MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHT
Roche Diagnostics
Thermo Fisher Scientific
Qiagen
Illumina
GE Healthcare
Bio-Rad Laboratories
Agilent Technologies
Novartis AG
Pfizer Inc.
Others
ASIA PACIFIC PERSONALIZED MEDICINE MARKET, BY PRODUCT - MARKET ANALYSIS, 2019 - 2032
Personalized Medicine Diagnostics
Personalized Medicine Therapeutics
Personalized Medical Care
Personalized Nutrition and Wellness
ASIA PACIFIC PERSONALIZED MEDICINE MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032
Oncology
CNS
Immunology
Respiratory
Others
ASIA PACIFIC PERSONALIZED MEDICINE MARKET, BY END-USER - MARKET ANALYSIS, 2019 - 2032
Hospitals
Diagnostic Centers
Research & Academic Institutes
Others
ASIA PACIFIC PERSONALIZED MEDICINE MARKET, BY COUNTRY- MARKET ANALYSIS, 2019 - 2032
India
China
South Korea
Japan
Australia
Thailand
Indonesia
Philippines
Rest of APAC
Table of Contents
1. Asia Pacific Personalized Medicine Market Overview
- 1.1. Study Scope
- 1.2. Market Estimation Years
2. Executive Summary
- 2.1. Market Snippet
- 2.1.1. Asia Pacific Personalized Medicine Market Snippet by Product
- 2.1.2. Asia Pacific Personalized Medicine Market Snippet by Application
- 2.1.3. Asia Pacific Personalized Medicine Market Snippet by End-User
- 2.1.4. Asia Pacific Personalized Medicine Market Snippet by Country
- 2.2. Competitive Insights
3. Asia Pacific Personalized Medicine Key Market Trends
- 3.1. Asia Pacific Personalized Medicine Market Drivers
- 3.1.1. Impact Analysis of Market Drivers
- 3.2. Asia Pacific Personalized Medicine Market Restraints
- 3.2.1. Impact Analysis of Market Restraints
- 3.3. Asia Pacific Personalized Medicine Market Opportunities
- 3.4. Asia Pacific Personalized Medicine Market Future Trends
4. Asia Pacific Personalized Medicine Industry Study
- 4.1. PEST Analysis
- 4.2. Porter's Five Forces Analysis
- 4.3. Growth Prospect Mapping
- 4.4. Regulatory Framework Analysis
5. Asia Pacific Personalized Medicine Market: COVID-19 Impact Analysis
- 5.1. Pre-COVID-19 Impact Analysis
- 5.2. Post-COVID-19 Impact Analysis
- 5.2.1. Top Performing Segments
- 5.2.2. Marginal Growth Segments
- 5.2.3. Top Looser Segments
- 5.2.4. Marginal Loss Segments
6. Asia Pacific Personalized Medicine Market Landscape
- 6.1. Asia Pacific Personalized Medicine Market Share Analysis, 2023
- 6.2. Breakdown Data, by Key Manufacturer
- 6.2.1. Established Players' Analysis
- 6.2.2. Emerging Players' Analysis
7. Asia Pacific Personalized Medicine Market - By Product
- 7.1. Overview
- 7.1.1. Segment Share Analysis, By Product, 2023 & 2032 (%)
- 7.1.2. Personalized Medicine Diagnostics
- 7.1.3. Personalized Medicine Therapeutics
- 7.1.4. Personalized Medical Care
- 7.1.5. Personalized Nutrition and Wellness
8. Asia Pacific Personalized Medicine Market - By Application
- 8.1. Overview
- 8.1.1. Segment Share Analysis, By Application, 2023 & 2032 (%)
- 8.1.2. Oncology
- 8.1.3. CNS
- 8.1.4. Immunology
- 8.1.5. Respiratory
- 8.1.6. Others
9. Asia Pacific Personalized Medicine Market - By End-User
- 9.1. Overview
- 9.1.1. Segment Share Analysis, By End-User, 2023 & 2032 (%)
- 9.1.2. Hospitals
- 9.1.3. Diagnostic Centers
- 9.1.4. Research & Academic Institutes
- 9.1.5. Others
10. Asia Pacific Personalized Medicine Market- By Geography
- 10.1. Introduction
- 10.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
- 10.2. Asia Pacific (APAC)
- 10.2.1. Overview
- 10.2.2. Asia Pacific Personalized Medicine Key Manufacturers in Asia Pacific
- 10.2.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.2.4. Asia Pacific Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 10.2.5. Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.2.6. Asia Pacific Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.2.7. India
- 10.2.7.1. Overview
- 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.2.7.3. India Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 10.2.7.4. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.2.7.5. India Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.2.8. China
- 10.2.8.1. Overview
- 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.2.8.3. China Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 10.2.8.4. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.2.8.5. China Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.2.9. Japan
- 10.2.9.1. Overview
- 10.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.2.9.3. Japan Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 10.2.9.4. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.2.9.5. Japan Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.2.10. South Korea
- 10.2.10.1. Overview
- 10.2.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.2.10.3. South Korea Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 10.2.10.4. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.2.10.5. South Korea Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.2.11. Australia
- 10.2.11.1. Overview
- 10.2.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.2.11.3. Australia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 10.2.11.4. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.2.11.5. Australia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.2.12. Thailand
- 10.2.12.1. Overview
- 10.2.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.2.12.3. Thailand Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 10.2.12.4. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.2.12.5. Thailand Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.2.13. Indonesia
- 10.2.13.1. Overview
- 10.2.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.2.13.3. Indonesia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 10.2.13.4. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.2.13.5. Indonesia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.2.14. Philippines
- 10.2.14.1. Overview
- 10.2.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.2.14.3. Philippines
- 10.2.14.4. Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 10.2.14.5. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.2.14.6. Philippines Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.2.15. Rest of APAC
- 10.2.15.1. Overview
- 10.2.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.2.15.3. Rest of APAC Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 10.2.15.4. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.2.15.5. Rest of APAC Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11. Key Vendor Analysis- Asia Pacific Personalized Medicine Industry
- 11.1. Competitive Dashboard
- 11.2. Company Profiles
- 11.2.1. Roche Diagnostics
- 11.2.2. Thermo Fisher Scientific
- 11.2.3. Qiagen
- 11.2.4. Illumina
- 11.2.5. GE Healthcare
- 11.2.6. Bio-Rad Laboratories
- 11.2.7. Agilent Technologies
- 11.2.8. Novartis AG
- 11.2.9. Pfizer Inc.
- 11.2.10. Others
12. 360 Degree Analyst View
13. Appendix
- 13.1. Research Methodology
- 13.2. References
- 13.3. Abbreviations
- 13.4. Disclaimer
- 13.5. Contact Us
List of Tables
- TABLE List of data sources
- TABLE Market drivers; Impact Analysis
- TABLE Market restraints; Impact Analysis
- TABLE Asia Pacific Personalized Medicine Market: Product Snapshot (2023)
- TABLE Segment Dashboard; Definition and Scope, by Product
- TABLE Asia Pacific Personalized Medicine Market, by Product 2019-2032 (USD Million)
- TABLE Asia Pacific Personalized Medicine Market: Application Snapshot (2023)
- TABLE Segment Dashboard; Definition and Scope, by Application
- TABLE Asia Pacific Personalized Medicine Market, by Application 2019-2032 (USD Million)
- TABLE Asia Pacific Personalized Medicine Market: End-User Snapshot (2023)
- TABLE Segment Dashboard; Definition and Scope, by End-User
- TABLE Asia Pacific Personalized Medicine Market, by End-User 2019-2032 (USD Million)
- TABLE Asia Pacific Asia Pacific Personalized Medicine Market, by Country, 2019-2032 (USD Million)
List of Figures
- FIGURE Asia Pacific Personalized Medicine Market Segmentation
- FIGURE Market research methodology
- FIGURE Value chain analysis
- FIGURE Porter's Five Forces Analysis
- FIGURE Market Attractiveness Analysis
- FIGURE COVID-19 Impact Analysis
- FIGURE Pre & Post COVID-19 Impact Comparision Study
- FIGURE Competitive Landscape; Key company market share analysis, 2023
- FIGURE Product segment market share analysis, 2023 & 2032
- FIGURE Product segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Application segment market share analysis, 2023 & 2032
- FIGURE Application segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE End-User segment market share analysis, 2023 & 2032
- FIGURE End-User segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Asia Pacific Asia Pacific Personalized Medicine Market share and leading players, 2023
- FIGURE Asia Pacific Asia Pacific Personalized Medicine Market share analysis by country, 2023
- FIGURE India Asia Pacific Personalized Medicine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE China Asia Pacific Personalized Medicine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Japan Asia Pacific Personalized Medicine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE South Korea Asia Pacific Personalized Medicine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Australia Asia Pacific Personalized Medicine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Thailand Asia Pacific Personalized Medicine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Indonesia Asia Pacific Personalized Medicine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Philippines Asia Pacific Personalized Medicine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Rest of APAC Asia Pacific Personalized Medicine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
